Clinical trial
Comparison of Efficacy and Safety Between Eleveld PK/PD Model-based Dosing and Standard Dosing During General Anesthesia
NCT07675850 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Efficacy and Safety Between Eleveld PK/PD Model-based Dosing and Standard Dosing During General Anesthesia
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- July 5, 2026
- Completion date
- May 31, 2027
- Enrollment
- 68 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pharmacokinetics and pharmacodynamics, remimazolam